A human antibody fragment, AbD15179, which is well characterized for its specificity for human CD44v6, an alternatively spliced CD44 isoform known to be overexpressed in 50% of colorectal cancers, was exploited for drug delivery in colon tumors [227]. This evidence concerns the gene CD44 and colonic neoplasm.